Rapid molecular identification of deletional hereditary persistence of fetal hemoglobin type 2 (HPFH-type2) (English)
- New search for: Goncalves, M. S.
- New search for: Figueiredo, M. S.
- New search for: Fahel, S.
- New search for: Nechtman, J.
- New search for: National Institutes of Health
- New search for: Institut national de la sante et de la recherche medicale
- New search for: Goncalves, M. S.
- New search for: Figueiredo, M. S.
- New search for: Fahel, S.
- New search for: Nechtman, J.
- New search for: Beuzard, Y.
- New search for: Lubin, B.
- New search for: Rosa, J.
- New search for: National Institutes of Health
- New search for: Institut national de la sante et de la recherche medicale
In:
New trends in therapy for hemoglobinopathies and thalassaemias: Sickle cell disease and thalassaemias; new trends in therapy
234
;
103
;
1995
-
ISBN:
-
ISSN:
- Conference paper / Print
-
Title:Rapid molecular identification of deletional hereditary persistence of fetal hemoglobin type 2 (HPFH-type2)
-
Contributors:Goncalves, M. S. ( author ) / Figueiredo, M. S. ( author ) / Fahel, S. ( author ) / Nechtman, J. ( author ) / Beuzard, Y. / Lubin, B. / Rosa, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale
-
Conference:International conference, New trends in therapy for hemoglobinopathies and thalassaemias: Sickle cell disease and thalassaemias; new trends in therapy ; 1994 ; Paris
-
Published in:
-
Publisher:
- New search for: John Libbey Eurotext
-
Place of publication:Paris , Les Editions INSERM
-
Publication date:1995-01-01
-
Size:103 pages
-
Remarks:Text in English, selected summaries in French
-
ISBN:
-
ISSN:
-
Type of media:Conference paper
-
Type of material:Print
-
Language:English
-
Keywords:
-
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents conference proceedings
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 3
-
Molecular control of globin gene switchingStamatoyannopoulos, G. / Li, Q. / Clegg, C. / Peterson, K. R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 9
-
Cis-/trans-regulation of chicken /curly epsilon-globin gene switchingEngel, J. D. / Foley, K. P. / Fraser, P. / Grosveld, F. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 19
-
Transcriptional regulation of the globin gene cluster (summary)Grosveld, F. / Fraser, P. / Philipsen, S. / Ellis, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 21
-
Functional analysis of human curly epsilon-globin gene silencerRaich, N. / Stamatoyannopoulos, G. / Romeo, P.-H. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 31
-
Transcriptional and post-transcriptional mechanisms of curly epsilon-globin gene silencing (summary)Noguchi, C. T. / Peters, B. / Kollia, P. / Fibach, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 33
-
Isolation of Nrf2, a NF-E2 like bZip transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the -globin LCRMoi, P. / Chan, K. / Asunis, I. / Marini, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 35
-
The transactivator CP2 is an integral component of the stage selector protein complexJane, S. M. / Nienhuis, A. W. / Cunningham, J. M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 43
-
A ferritin-like protein binds to a highly conserved CAGTGC sequence in the -globin promoterBroyles, R. H. / Blair, F. C. / Kyker, K. D. / Kurien, B. T. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 53
-
Somatic cell hybrids from transgenic mice in the analysis of embryonic fetal and adult globin gene regulationStanworth, S. J. / Roberts, N. A. / Sharpe, J. A. / Sloane-Stanley, J. A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 65
-
Regulation of the human -globin gene clusterHiggs, D. R. / Craddock, C. F. / Sharpe, J. A. / Gourdon, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 75
-
Targeted inactivation of the HS-40 element of the human -globin gene locus via homologous recombinationBernet, A. / Sabatier, S. / Ouazana, R. / Morle, F. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 85
-
Nonsense mutated -globin mRNA: pathways of nuclear metabolism and possible significance for the protection against ineffective erythropoiesis in heterozygous -thalassemiaKulozik, A. E. / Kugler, W. / Enssle, J. / Hentze, M. W. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 97
-
Molecular basis of -thalassemia in Belgian families: detection of a novel frameshift mutationDerclaye, I. / Heusterspreute, M. / Malchaire, Y. / Philippe, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 98
-
Variation in fetal haemoglobin (HbF) levels among children with sickle cell anaemia in the UK the predominant Benin haplo-typeOfori-Acquah, S. F. / Pandya, J. K. / Henderson, S. / Bellingham, A. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 99
-
-thalassemia mutations in IsraelTamary, H. / Shalmon, L. / Kirschmann, C. / Zaizov, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 100
-
Role of a region upstream of human -globin gene on the regulation of globin genes expressionVitale, M. / Di Marzo, R. / Calzolari, R. / Acuto, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 101
-
Diameteric regulation of human gamma globin and GATA-1 genes by short chain fatty acidsCaron, C. M. / Voss, J. W. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 102
-
The mouse -globin HS40-like element does not have LCR activity in transgenic mice when linked to the human -globin geneBouhassira, E. E. / Kielman, M. F. / Suzuka, S. / Bernini, L. F. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 103
-
Rapid molecular identification of deletional hereditary persistence of fetal hemoglobin type 2 (HPFH-type2)Goncalves, M. S. / Figueiredo, M. S. / Fahel, S. / Nechtman, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 104
-
Novel mutations of -thalassaemia located in the untranslated regions of the -globin geneAthanassiadou, A. / Papachadjopoulou, A. / Zoumbos, N. / Maniatis, G. M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 105
-
Detecting African-American -thalassemia mutations using a single, rapid reverse dot blot hybridizationSutcharitchan, P. / Saiki, R. / Kutlar, A. / McKie, V. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 106
-
Homozygous -thalassemia with carrier state phenotypeRosatelli, M. C. / Pischedda, A. / Meloni, A. / Saba, L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 107
-
Localisation of a major gene for heterocellular HPFH to a region of chromosome 6qCraig, J. E. / Rochette, J. / Fisher, C. / Weatherall, D. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 111
-
Prospects for stem cell gene therapy (summary)Valerio, D. / Hoogerbrugge, P. / Van Beusechem, V. / Einerhand, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 113
-
Safe and efficient retroviral-mediated gene transfer into human hematopoietic progenitors (summary)Bank, A. / Ward, M. / Richardson, C. / Podda, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 115
-
Critical issues in the genetic treatment of hemoglobinopathiesSadelain, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 125
-
Progress towards the gene therapy of human -globin gene disorders using retroviral vectors that transfer -globin gene and -locus control region derivativesLeboulch, P. / Takekoshi, K. J. / Pawliuk, R. / Humphries, R. K. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 135
-
Retroviral transfer of a human gamma-globin gene linked to the -globin locus control region (LCR) results in high level expression in mouse erythroleukemia cellsAtweh, G. F. / Ren, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 137
-
Recombinant adeno-associated virus (rAAV) mediated transduction and expression of a human gamma-globin gene in CD34^+ selected peripheral blood cells from a patient with sickle cell anemiaMiller, J. L. / Donahue, R. E. / Sellers, S. E. / Samulski, R. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 141
-
Gene therapy strategy for sickle cell disease: transduction of pluripotent stem cells by AAV vectors (summary)Luhovy, M. / McCune, S. / Dong, J. Y. / Townes, T. M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 143
-
Gene therapy approaches in thalassaemia using P1-derived artificial chromosomes (PACs) and antisense oligonucleotidesIoannou, P. / Georghiou, A. / Bashiardes, E. / Kleanthous, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 145
-
Sustained delivery of erythropoietin in mice by genetically-modified skin fibroblastsNaffakh, N. / Henri, A. / Villeval, J.-L. / Rouyer-Fessard, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 151
-
Adenovirus vector for the erythropoietin gene transferBlumenfeld, N. / Descamps, V. / Villeval, J.-L. / Kremer, E. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 157
-
Reversal of aberrant splicing of thalassemic pre-mRNAs by antisense oligonucleotidesKole, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 165
-
Hydroxyurea effects in sickle cell anemia and -thalassemia patients result from both transcriptional and cell selection mechanisms (summary)Rodgers, G. P. / Zeng, Y. T. / Schechter, A. N. / Huang, S. Z. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 167
-
Hydroxyurea: an alternative treatment for recurrent stroke in selected sickle cell disease patients?Steinberg, M. H. / Ware, R. E. / Kinney, T. R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 169
-
Clinical and hematological response of sickle cell children to treatment with hydroxyureaDe Montalembert, M. / Belloy, M. / Bernaudin, F. / Philippe, N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 171
-
Hydroxyurea treatment in severely affected sickle cell disease childrenBelloy, M. / Ducrocq, R. / De Montalembert, M. / Krishnamoorthy, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 173
-
Hydroxyurea/erythropoietin combination therapy for sickle cell diseaseEl-Hazmi, M. A. F. / Harakati, M. / Mohareb, F. / Al-Momen, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 177
-
Lessons for prospective clinical trials in the treatment of sickle cell anemia from the multicenter study of hydroxyureaCharache, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 185
-
Clinical trials with hydroxyurea in GreeceLoukopoulos, D. / Voskaridou, E. / Stamoulakatou, A. / Papasotiriou, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 193
-
Hydroxyurea therapy in thalassemia intermediaCohen, A. R. / Martin, M. B. / Schwartz, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 195
-
Clinical effects of hydroxyurea in thalassemia intermedia patients (summary)Bachir, D. / Drame, M. / Lee, K. / Portos, J.-L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 197
-
Combination of erythropoietin and hydroxyurea results in improved quality and quantity of RBC in 7 patients with thalassemia intermediaAker, M. / Dover, G. / Schrier, S. / Rachmilewitz, E. A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 201
-
Hydroxyurea increases Hb F levels and improves the effectiveness of erythropoiesis in -thalassemia/Hb E diseaseFucharoen, S. / Siritanaratkul, N. / Chaicharoen, S. / Poolsup, N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 203
-
Long-term treatment with recombinant human erythropoietin in patients with thalassemia: reduction in requirement for transfusion and chelation therapyOlivieri, N. F. / MacKinnon, J. / Collins, A. F. / Sher, G. D. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 207
-
Beneficial use of r-HuEPO in sickle cell disease and thalassemia intermedia: interim results (summary)Cozma, G. / Momen, A. K. / Hazmi, M. A. F. / Politis, C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 209
-
Oral sodium phenylbutyrate therapy in homozygous thalassemia: a clinical trialCollins, A. F. / Pearson, H. A. / Giardina, P. / McDonagh, K. T. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 215
-
A novel butyric acid derivative stimulates fetal hemoglobin expressionRephaeli, A. / Zimra, Y. / Nudelman, A. / Ben-Dror, I. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 217
-
The two-phase liquid culture of human erythroid progenitors: application for studying sickling of erythroblasts from patients with sickle cell anemia (SCA)Fibach, E. / Hasegawa, S. / Schechter, A. N. / Noguchi, C. T. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 219
-
HbF induction in presence of increased 2-methyl-3-hydroxybutyric acid associated with 2-methylacetoacetil-CoA deficiency (summary)Galanello, R. / Lilliu, F. / Contini, L. / Podda, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 223
-
Effects of alpha-thalassemia and hemoglobin F level on the severity of sickle cell anemiaLima, J. C. S. / Fleury, M. K. / Falcao, D. N. C. / Lobo, C. L. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 224
-
Effect of hydroxyurea (HU) in patients with -thalassemia intermediaMandala, E. / Sinakos, Z. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 225
-
Induction of fetal hemoglobin by butyrate analogues in erythroid liquid culture from human peripheral blood stem cellsCappellini, M. D. / Stefanoni, I. / Tomaselli, C. / Bianchi, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 226
-
Increased O~2 affinity conferred by hydroxyurea induced HbF in sickle cell disease is not adequate to prevent HbS polymerizationStamoulakatou, A. / Papassotiriou, I. / Perissaki, G. / Stamou, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 227
-
Erythropoietin induced increase of hemoglobin F in thalassemia intermedia does not contribute significantly to tissue oxygenationPapassotiriou, I. / Stamoulakatou, A. / Premetis, E. / Papalabrou, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 228
-
Administration of rHuEpo in sickle cell--thalassemia double heterozygotes during pregnancy and orthopedic surgeryBourantas, K. / Georgiou, J. / Malizos, K. / Tsiara, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 229
-
Long term efficacy of recombinant human erythropoietin in the treatment of patients with -haemoglobinopathiesPolitis, C. / Fragatou, S. / Hatzilaos, I. / Tzioka, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 230
-
Intravenous arginine butyrate therapy in patients with betahaemoglobinopathies: results of the Canadian trialSher, G. D. / Ginder, G. / Chang, L. / Dover, G. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 231
-
Recombinant human erythropoietin induced rapid and complete healing of chronic leg ulcers in two patients with thalassaemia intermediaPolitis, C. / Fragatou, S. / Messimeris, T. / Vrettou, H. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 232
-
Efficacy of hydroxyurea in treatment of Egyptian patients with -thalassaemia: preliminary results of a pilot clinical studyHassan, H. T. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 233
-
In vitro studies and HPLC determinations demonstrate that hydroxyurea may also induce denaturation of normal and sickle cell hemoglobinRoa, D. / Turner, E. A. / Roa, A. C. / Kopsombut, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 234
-
Possible pharmacological manipulation of calcium ion from intracellular stores and stimulation of HbF synthesis in sickle cell disease by NX06999Fadulu, S. O. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 235
-
Hydroxyurea and phenylacetate decrease the number of BFU-E colonies in vitro in erythroid progenitors derived from sickle cell patientsYang, Y. M. / Baliga, B. S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 236
-
On a case of thalassemia intermedia and isoimmune hemolytic anaemia treated with rHuEpoTannoia, N. / Pietrapertosa, A. / Vitucci, A. / Ranieri, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 237
-
Asociation of a 5' HS2-(AT)~XN~1~2(AT)~Y polymorphisms with levels of HbF and HbF/F cellPerichon, B. / Meier-Redelsperger, M. / Ducrocq, R. / Schilliroe, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 241
-
Expression of normal and HPFH human globin genes in transgenic miceRomana, M. / Starck, J. / Scarpa, A. L. / Sarkar, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 251
-
Deletion of mouse -globin and mouse -globin genes in embryonic stem cells (summary)Ciavatta, D. / Ryan, T. / Farmer, S. / McCune, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 253
-
Strategies for amelioration of sickle cell disease: use of the transgenic mouse for validation of antisickling strategiesFabry, M. E. / Suzuka, S. M. / Rubin, E. M. / Costantini, F. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 263
-
The SAD phenotype: sickle cell disease reproduced in transgenic miceDe Paepe, M. E. / Sorette, M. / Chretien, N. / Saadane, N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 271
-
rHuEPO, hydroxyurea and combined treatments in mouse -thalassemia: a model for treatment of human -thalassemiaDe Franceschi, L. / Rouyer-Fessard, P. / Brugnara, C. / Beuzard, Y. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 275
-
Decontamination of red cell componentsCorash, L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 285
-
Preoperative transfusion (TX) in sickle cell anemia (SCA)Vichinsky, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 287
-
Total blood transfusion in Zairian children and young adults suffering from sickle cell diseaseTshilolo, M. L. / Mukendi, K. R. / Wembonyama, O. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 289
-
Transfusion and infections in thalassaemia major (summary)Eleftheriou, A. / Angastiniotis, M. / Ioannou, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 291
-
Oxygen transport by cell-free oxygen carriersWinslow, R. M. / Intaglietta, M. / Vandegriff, K. D. / Tsai, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 301
-
A phase I study of polymerized bovine hemoglobin (PBH) in adult patients with sickle cell disease not in crisis at the time of studyOrringer, E. P. / Gonzalez, P. M. / Hackney, A. C. / Jones, S. K. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 303
-
Strategies for blood substitutes: lessons from chemical modification and mutagenesis studies of hemoglobinManning, J. M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 305
-
Oxygen delivery using perfluorochemicals (summary)Riess, J. G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 307
-
Post-transfusion viral infection in patients with thalassaemiaDe Montalembert, M. / Lefrere, J.-J. / Girot, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 309
-
-IFN in thalassemic patients with chronic hepatitis C virusFilosa, A. / Saviano, A. / Aponte, S. / Capasso, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 313
-
Structural and aggregation properties of a recombinant hemoglobin double mutant: sickle hemoglobin with Leu-88 () at the primary aggregation site substituted by AlaDe Llano, J. J. M. / Benjamin, L. J. / Manning, J. M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 314
-
The frequency of blood borne viruses (HBV, HCV and HIV) among Egyptian thalassemic childrenEl-Beshlawy, A. / Kaddah, N. / El-Hassan, A. A. / Eshak, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 315
-
Ten years clinical and hematological follow-up of HIV infected patients with thalassemiaLadis, V. / Theodoridou, M. / Berdoussi, H. / Mandalenaki, K. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 316
-
Viral infections in -thalassaemia multitransfused patientsMeo, A. / Miceli, M. / Cilia, S. / Minutoli, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 317
-
Prevalence of HCV antibodies in thalassaemiaMeo, A. / Miceli, M. / Cilia, S. / Minutoli, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 318
-
Effectiveness of low-dose intradermal hepatitis B vaccination in thalassemic patients: five years follow-upLeonardi, S. / Barone, P. / Sciacca, A. / Di Gregorio, F. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 319
-
Deferoxamine and interferon in thalassemic patients with chronic C hepatitis: does exist a therapeutic synergism?Leonardi, S. / Musumeci, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 320
-
Periodical model of hematopoiesis in thalassemic peopleFilosa, A. / Giani, U. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 321
-
Hepatitis C in patients with thalassemia and sickle cell syndromThuret, I. / Badens, C. / Michel, G. / Chambost, H. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 322
-
Thalassemia or thalassemic: towards a personalization of the transfusional regimen. A preliminary studyFilosa, A. / Esposito, G. / Galati, M. G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 323
-
Hepatitis markers in Brazilian patients with sickle cell diseasesArruda, V. R. / Eid, K. A. B. / Zen, G. C. / Goncalves, N. S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 324
-
The effect of chronic transfusion on sickle cell related illnessesStyles, L. / Vichinsky, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 325
-
Transfusion inefficiency and unexplained anaemia in sickle cell anaemiaSegbena, A. / Sanogo, I. / Ambofo, Y. / Sangare, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 326
-
Blood transfusions aspects in sickle cell anaemia patients in pediatrics at the Lome-Tokoin teaching hospitalSegbena, A. / Vovor, A. / Eko-Mba, J. M. / Tatagan, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 329
-
Studies of the orally active iron chelating agent deferiprone (L1) in thalassemiaOlivieri, N. F. / Brittenham, G. M. / Matsui, D. / Berkovitch, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 337
-
Clinical studies with the oral iron chelator deferiprone (L1)Al-Refaie, F. N. / Wonke, B. / Hoffbrand, A. V. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 349
-
Therapeutic potential of iron chelating treatment: modification of disease by iron depletionHershko, C. / Link, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 359
-
Effect of iron loading on the metabolism and urinary recovery of 3-hydroxypyridin-4-one chelating agents in the ratChoudhury, R. / Singh, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 361
-
A fast, sensitive method to evaluate the potential of Fe-chelators to mobilize zinc (summary)Faller, B. / Nick, H. P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 363
-
Factors affecting the efficacy and toxicity of deferiprone (L1) in transfusional iron loaded patientsKontoghiorghes, G. J. / Sheppard, L. / Bartlett, L. / Bruckdorfer, K. R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 367
-
Design and development of orally active chelating agents: selective targeting of chelatable iron poolsSingh, S. / Choudhury, R. / Hider, R. C. / Porter, J. B. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 369
-
Further evaluation of HBED as an oral iron chelatorGrady, R. W. / Salbe, A. D. / Hilgartner, M. W. / Giardina, P. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 371
-
Thymocyte apoptosis: a rapid model for comparative screening of iron chelators. Implications for treatment of iron overload in thalassaemiaPorter, J. B. / Lynagh, G. R. / Hider, R. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 373
-
Long-term intravenous deferoxamine treatment for non-compliant transfusion-dependent beta-thalassemia patientsTamary, H. / Goshen, J. / Carmi, D. / Yaniv, I. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 375
-
Treatment of iron stores in thalassemic patients with a regimen of continuous intravenous deferoxamine by a new disposable deviceLombardo, T. / Frontini, V. / Tamburino, C. / Bartoloni, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 377
-
The effect of low dose desferrioxamine on ototoxicity in hemoglobinopathy patientsStyles, L. / Vichinsky, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 381
-
Update of iron chelation therapy with oral L~1 (deferiprone) worldwideKontoghiorghes, G. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 382
-
Recommendations for the use and monitoring of the oral chelating drug L1 or deferiprone by the I.C.O.C. committeeAgarwal, M. B. / Kontoghiorghes, G. J. / Tondury, P. / Kersten, M. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 383
-
A novel high molecular weight iron chelator produces prolonged, high plasma chelator levels in humansHedlund, B. E. / Hallaway, P. E. / Hanson, G. J. / Kling, P. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 387
-
The ethics of prenatal diagnosis in different religious and cultural contextsWasi, P. / Fucharoen, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 389
-
Design and execution of clinical trials for the treatment of sickle cell anemiaCharache, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 395
-
From Hippocrates to hypothesis and beyond: how ethical is our research?Smith, J. A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 405
-
Ethics of bone marrow transplantation for sickle cell diseaseBernard, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 411
-
Ethical problems in bone marrow transplantation for hemoglobinopathiesPiomelli, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 419
-
Ethical issues and fetal stem cell transplantation for -thalassemia-1Hayward, A. R. / Battaglia, F. / Hobbins, J. / Hsia, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 423
-
The cost of sickle cell disease in a developing country: an assessment of the economic cost in the Commonwealth of DominicaCallender, D. P. E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 427
-
Recent research developments in sickle cell disease in JamaicaSerjeant, G. R. / Serjeant, B. E. / Homi, J. / Knight, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 431
-
Ketorolac versus meperidine in vasooclusive crisis: a study of safety and efficacyGrisham, J. E. / Vichinsky, E. P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 433
-
Frequently recurring pain in sickle cell disease: assessment, treatment and prevention strategies (summary)Benjamin, L. / Swinson, G. / Fulchon, C. / McKegney, F. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 435
-
Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemiaVichinsky, E. / Williams, R. / Das, M. / Earles, A. N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 443
-
Death in sickle cell disease. The unexpected and the unexplainedDavies, S. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 445
-
Can transfusion therapy prevent the first stroke in children with sickle cell anemia who are found by transcranial Doppler to have high cerebral artery flow velocity?Pegelow, C. H. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 447
-
Experience of genetic counseling and prenatal diagnosis for sickle-cell anemia in Guadeloupe, French West Indies (summary)Berchel, C. / Keclard, L. / Saint-Martin, C. / Diara, J.-P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 449
-
Progress in the management of thalassemia major: a decade and a half of experienceGiardina, P. J. / Ehlers, K. W. / Grady, R. W. / New, M. I. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 451
-
Correction of primary and secondary amenorrhoea and induction of ovulation by pulsatile infusion of gonadotrophin releasing hormone (GnRH) in patients with beta thalassaemia majorChatterjee, R. / Wonke, B. / Porter, J. B. / Katz, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 457
-
Molecular pathology and diagnosis of -thalassemia intermediaCao, A. / Galanello, R. / Rosatelli, M. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 467
-
Hypercoagulability in patients with thalassemia intermediaCappellini, M. D. / Coppola, R. / Bottasso, B. / Potenza, I. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 469
-
Adrenarche and osteoporosis in prepubertal thalassemic patientsFilosa, A. / Di Maio, S. / Aponte, S. / Vocca, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 473
-
Neonatal screening for haemoglobinopathies in an English health regionHenthorn, J. / Nikolic, D. / Matthews, J. / Davies, S. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 474
-
A seven year community experience of prenatal diagnosis (PND) for the haemoglobinopathies. Factors affecting uptakeDugan, B. T. A. / Acheampong, C. / Graham, V. V. / Okuyiga, E. O. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 475
-
Everyday life with sickle cell disease (SCD). The lessons from health diariesShand, P. A. X. / Fuggle, P. / Davies, S. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 476
-
Selection of neonates for haemoglobinopathy screening by midwives does not workHenthorn, J. S. / Nikolic, D. / Davies, S. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 477
-
Implementation of new treatment modalities for sickle cell patients in GermanyDickerhoff, R. / Klingebiel, T. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 478
-
Is piracetam useful in the treatment of sickle cell disease?El-Hazmi, M. A. F. / Warsy, A. S. / Opawoye, A. D. / Abu Taleb, H. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 479
-
Echocardiographic evaluation in -thalassemia major (10 years follow-up)Meo, A. / Calabro, M. P. / Nicosia, S. / Cavalli, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 480
-
Glucose tolerance in thalassaemia patientsMeo, A. / Miceli, M. / Zappia, M. / Bianchini, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 481
-
Epidemiology survey of thalassemia trait in North East SicilyLa Rosa, M. A. / Meo, A. / Cafiero, G. / Cilia, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 482
-
Current skeletal findings in beta-thalassemia, following comprehensive therapyOrzincolo, C. / Castaldi, G. / Bariani, L. / Scutellari, P. N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 483
-
May vitamin A influence growth in homozygous thalassemic patients?Piga, A. / Sacchetti, L. / Garofalo, F. / Bertola, U. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 484
-
Natural history of sickle cell disease in Southern Zaire displays clinical specificitiesTshilolo, L. M. / Elion, J. / Girot, R. / Labie, D. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 485
-
Monitoring of RBC and reticulocyte hydration status and sickling-induced fragmentation during treatment of sickle cell anemia with hydroxyureaBallas, S. K. / Sorette, M. / Greenbaum, A. / Cremins, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 486
-
Erythropoietin treatment of anemic crises in sickle cell patientsCastro, O. / Osuji, I. / Perlin, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 487
-
Protein C deficiency and cerebrovascular accident in a thalassemia patientKoren, A. / Abu Hana, M. / Peleg, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 488
-
Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life. Parisian prospective study on sickle cell disease (PPSSCD)Maier-Redelsperger, M. / Noguchi, C. T. / De Montalembert, M. / Rodgers, G. P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 489
-
Impact of counselling on the management of sickle cell disorders in AfricaOtaigbe, A. / Akinyanju, O. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 490
-
Self-medication of painful sickle cell episodesAkinyanju, O. / Otaigbe, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 491
-
Rapid healing of chronic leg ulcers in patients with thalassaemia during treatment with hydroxyureaDi Palma, A. / Olivieri, N. / Sprocati, M. / Tenan, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 492
-
Prevalence of complications in medically treated thalassemia major and relation to iron burdenBorgna-Pignatti, C. / Rugolotto, S. / Verlato, G. / De Stefano, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 495
-
Molecular basis for sickle cell adhesion to endothelium: potential implications for therapeutic strategies (summary)Mohandas, N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 497
-
Platelet-activating factor enhances adhesion of sickle erythrocytes to vascular endothelium: the role of vascular integrin ~v~3 and von Willebrand factorKaul, D. K. / Tsai, H. M. / Nagel, R. L. / Chen, D. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 501
-
Increased serum levels of phospholipase A~2 and free fatty acid in sickle cell disease associated with acute chest syndrome (ACS)Kuypers, F. A. / Styles, L. / Schalkwijk, C. G. / Hassell, K. L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 505
-
VCAM-1 is involved in mediating hypoxia-induced adherence of sickle red blood cells to both macro- and micro-vascular endothelium (summary)Stuart, M. J. / Setty, Y. B. N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 507
-
Microcirculation patterns in sickle cell disease (SCD) and assessment of therapeutic effects (buflomedil, HU)Bachir, D. / Maurel, A. / Beuzard, Y. / Portos, J.-L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 511
-
Oxidative processes in the pathobiology of sickle cell disease: potential opportunities for therapeutic interventionHebbel, R. P. / Repka, T. / Shalev, O. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 517
-
Protection of the erythrocyte membrane calmodulin stimulated Ca^+^+-ATPase against iron induced inhibition by U83836E (a vitamin E analog)Zaidi, A. / Marden, M. C. / Poyart, C. / Leclerc, L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 519
-
Oxidative stress in -thalassemic red blood cells and potential use of antioxidantsGrinberg, L. N. / Rachmilewitz, E. A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 525
-
Blockade of erythrocyte Ca^2^+-actived K^+ transport: a potential new therapeutic approach for sickle cell diseaseBrugnara, C. / Armsby, C. C. / Sakamoto, M. / Rifai, N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 535
-
Dipyridamole inhibits deoxygenation-induced cation fluxes in sickle cellsJoiner, C. H. / Jiang, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 545
-
Magnesium therapy for sickle cell anemia: a new rationaleBookchin, R. M. / Tiffert, J. T. / Davies, S. C. / Vichinsky, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 547
-
Two pathways for dense cell formation in sickle cells exposed to repeated in vitro cycles of oxygenation-deoxygenationSchwartz, R. S. / Musto, S. / Suzuka, S. M. / Nagel, R. L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 549
-
Compensatory mutations can restore function in mutant hemoglobinsHo, C. / Kim, H. W. / Shen, T. J. / Sun, D. P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 551
-
Polymerization of recombinant hemoglobin ~2~26(A3) Glu >Val, 7(A4) Glu >AlaLesecq, S. / Baudin, V. / Kiger, L. / Jonval, V. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 553
-
Design, synthesis, oxygen affinity and X-ray crystallographic studies of a novel class of covalent cross-linkers of hemoglobin subunitsBoyiri, T. / Safo, M. K. / Danso-Danquah, R. E. / Orringer, E. P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 555
-
Antisickling by metabolic depletion of erythrocyte 2,3-DPGPoillon, W. N. / Kim, B. C. / Kark, J. A. / Hicks, C. U. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 557
-
A recombinant biphosphoglycerate mutase variant with acid phosphatase homology degrades 2,3-diphosphoglycerate: a possible new therapeutic approach of sickle cell diseaseGarel, M.-C. / Arous, N. / Calvin, M.-C. / Craescu, C. T. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 561
-
Membrane protein phosphorylation and sickle cell dehydrationFathallah, H. / Coezy, E. / De Neef, R. S. / Hardy-Dessources, M. D. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 562
-
Heme degradation in the presence of glutathione: a proposed mechanism for heme degradation in abnormal red blood cellsAtamna, H. / Ginsburg, H. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 565
-
Bone marrow transplantation in thalassemiaLucarelli, G. / Galimberti, M. / Angelucci, E. / Baronciani, D. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 571
-
Collaborative study of marrow transplantation for symptomatic sickle cell anemia (summary)Sullivan, K. M. / Walters, M. C. / Bernaudin, F. / Souillet, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 573
-
Allogeneic bone marrow transplantation in severe pediatric sickle cell disease: report of the French experience with 22 casesBernaudin, F. / Souillet, G. / Vannier, J.-P. / Vilmer, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 579
-
Patients with sickle cell anemia who present graft failure after bone marrow transplantation may develop increased levels of fetal hemoglobin associated with improved clinical presentationFerster, A. / Corazza, F. / Bujan, W. / Devalck, C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 581
-
Origin of different hematologic lineages in stable mixed chimeras after BMT in thalassemiaAndreani, M. / Nesci, S. / Manna, M. / Tonucci, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 583
-
Use of cord blood for treament of patients with congenital hemoglobinopathiesGluckman, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 589
-
Functional studies of human long-term culture-initiating cells (LTC-IC) in vitro and in vivoEaves, C. / Zandstra, P. / Ponchio, L. / Cashman, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 595
-
Expansion of cord blood progenitor cells from unfractionated samples (summary)Gabutti, V. / Miniero, R. / Crescenzio, N. / Ruggieri, L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 597
-
In utero hematopoietic stem cell transplantationsZanjani, E. D. / Flake, A. W. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995